Friday, 10 July 2026European Markets

#Parkinson's disease

2 articles

Novo Nordisk Exits Internal Cell Therapy, Licenses Parkinson's Program to AI Partner

European Biotech

Novo Nordisk Exits Internal Cell Therapy, Licenses Parkinson's Program to AI Partner

Salvado•Jun 25, 2026

Novo Nordisk Closes Cell Therapy Unit, Outsources Parkinson's to AI-Native Partner

European Pharma

Novo Nordisk Closes Cell Therapy Unit, Outsources Parkinson's to AI-Native Partner

Salvado•Jun 19, 2026